http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2018003691-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58592c27c5de9fd65e0dbd351dcecb3c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L26-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 |
| filingDate | 2018-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49dd9c088b6a3bb60af94f84a1267767 |
| publicationDate | 2019-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CL-2018003691-A1 |
| titleOfInvention | Hemostatic tissue of medicated oxidized cellulose |
| abstract | A hemostatic tissue of medicated oxidized cellulose, comprising a sterile fibrillar or woven network (mesh) of oxidized tissue reabsorption cellulose combined with 100 mg of tranexamic acid, 5 mg of ephedrine and 100 mg of calcium chloride per 1,000 mg of Oxidized tissue reabsorption cellulose and a sufficient amount of excipients necessary to deliver a stable tissue that do not modify the composition of the active ingredients of the preparation. |
| priorityDate | 2018-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.